Affiliation:
1. Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
2. Emergency and Critical Care Center, Kyushu University Hospital, Fukuoka, Japan.
Abstract
Objectives:
To develop an equation for defining a low skeletal muscle mass (SMM) in children and to investigate risk factors and outcomes associated with low SMM in critically ill pediatric patients.
Design:
Single-center retrospective pediatric cohorts, 2011–2018.
Setting:
Tertiary Emergency and Critical Care Center of Kyushu University Hospital in Japan.
Patients:
We studied two cohorts of pediatric patients 1–15 years old who underwent abdominal CT at the level of the third lumbar vertebra (L3). First a cohort of trauma patients presented to the emergency department in whom we developed an SMM regression equation. Second, a cohort of patients who had undergone abdominal CT within 3 days of PICU admission.
Interventions:
None.
Measurements and Main Results:
The equation for estimating normal SMM used sex, age, and weight. Low SMM was defined as less than 80% of normal. In the 112 patients in the PICU cohort, median (range) age was 68 (13–191) months, and 83 (74.1%) had underlying disease. There was low SMM in 54 patients (48.2%). Regarding associations, using odds ratio (OR) and 95% CI, we found that low dietary intake (OR 4.33 [95% CI, 1.37–13.70]; p = 0.013) and the presence of underlying disease (OR 7.44 [95% CI, 2.10–26.30]; p = 0.002) were independently associated with greater odds of low SMM. Low SMM, compared with normal SMM, was also associated with longer hospital stays (42.5 d vs. 20.5 d; p = 0.007; β, 1.59; 95% CI, 1.09–2.33; p = 0.016).
Conclusions:
In this retrospective PICU cohort from a single center in Japan, we found that low SMM at PICU admission was present in almost half the cases. Low SMM, as defined by being less than 80% of the normal, was associated with greater odds of low dietary intake and underlying chronic disease. Furthermore, low SMM was associated with longer hospital stays.
Publisher
Ovid Technologies (Wolters Kluwer Health)